UPC Analytics
ENDE
Overview · Filed:

UPC_APP_54972/2024

NOVEL ANTITUMORAL USE OF CABAZITAXEL

Procedural & sub-applicationsOther ProceduralMunich LDApplication Rop305
  • 2025-01-07Procedural onlyproceduralApplication Rop305

    The Munich Local Division judge-rapporteur issued a procedural order in the Sanofi pharmaceutical infringement actions (UPC_CFI_145-148/2024) granting the substitution of Sanofi-Aventis France by Sanofi Winthrop Industrie as a party following a corporate merger, under R. 310 RoP. The order addressed the allocation of court fees and costs between multiple claimant entities in relation to the French territory claims.